Publication:
An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor–Refractory ALK-Positive or ROS1-Positive NSCLC

Citation
Viola W. Zhu, Yen Ting Lin, Dong Wan Kim, Herbert H. Loong, Misako Nagasaka, Hao To, Yvonne Li En Ang, Chan Young Ock, Nishan Tchekmedyian, Sai Hong Ignatius Ou, Nicholas L. Syn, Thanyanan Reungwetwattana, Chia Chi Lin, Ross A. Soo (2020). An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor–Refractory ALK-Positive or ROS1-Positive NSCLC. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/58338.
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
View online Resources
Collections